Novo Nordisk(NYSE:NVO) 
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1...
Website: http://www.novonordisk.com
Founded: 1923
Full Time Employees: 44,326
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 65.23
H 65.47
L 62.37
C 62.51
V 10,849,631
10EMA 62.51
20EMA 62.51
60EMA 62.51
120EMA 62.51
250EMA 62.51